SCAI Publishes Guidelines for Device Selection in Femoral-Popliteal Arterial Interventions

May 1, 2018—The Society for Cardiovascular Angiography and Interventions (SCAI) announced the release of new guidelines that address the selection of specific categories of devices when endovascular therapy is indicated. The first-of-its-kind document by Dmitriy N. Feldman, MD, et al is available for an early viewing online in SCAI’s Catheterization and Cardiovascular Interventions.

According to SCAI, the purpose of this document is to provide a review of comparative effectiveness data, including safety and efficacy of femoral-popliteal devices, and to provide clinicians with guidance and recommendations for device selection when these devices are intended as the definitive or adjunctive therapy.

The SCAI writing group reviewed and considered data on safety, efficacy, and cost-effectiveness when making device-specific recommendations. Data sources included randomized clinical trials, meta-analyses, nonrandomized trials, observational studies, case series, and registry data.

The document, which makes recommendations for both definitive and adjunctive therapy scenarios, identified several areas for future research, including trials on value and cost-effectiveness of devices in specific clinical circumstances and lesion subsets.

In addition, the guidelines recommend that future studies adopt the Peripheral Academic Research Consortium definitions for clinically meaningful outcomes and endpoints.

SCAI stated that the recommendations in this consensus guidelines document are a first step to provide clinicians with relevant anatomical scenarios to guide device selection based on strength and quality of evidence for comparative effectiveness, durability, and expert opinion.

In the SCAI announcement, Dr. Feldman, who served as Chair of the writing group, commented, “SCAI has a long history of prioritizing quality initiatives in the field of endovascular therapy for peripheral artery disease. Device choices for endovascular therapy, particularly in the femoral-popliteal interventions, remain challenging due to a wide spectrum of available device options and a paucity of comparative effectiveness data.”

Dr. Feldman continued, “Current guidelines do not address the selection of specific devices when endovascular therapy is indicated. This is the first SCAI-led device-focused consensus guidelines document, which provides a focused review of comparative effectiveness and safety data for femoral-popliteal devices.”